Davis (5) isolated several adenoviruses from fecal specimens from cases of infectious hepatitis which occurred in 1959 on the San Carlos Apache Indian Reservation in Arizona. Eight of the agents were identified as adenovirus type 3 (8) . AU eight agents showed the same differences from the prototype in their hemagglutinating properties and in their homologous and heterologous neutralization titers. These differences suggested that the eight probably represented a variant or substrain.
Biochemical patterns, similar to those caused by infectious hepatitis in humans, were reported by Douglas and Berge (6) in chimpanzees inoculated with one of the eight isolates designated as SC8. Although this positive evidence was not supported by the low rate with which adenoviruses were isolated subsequently from humans with the disease, it stimulated additional studies in our laboratory; in these studies radioactive viruses were used to determine the initial site of infection in chimpanzees and the materials from which virus might be isolated most readily. The initial, steps in these studies were the preparation and purification of '4C-labeled SC8 grown in cell cultures with media fortified with thymidine-2-14C. Study of the material obtained by fractionation of the radioactive SC8 preparations provided additional information on differences between this viral isolate and the prototype adenovirus 3. These data are reported here.
MATERIALS AND METHODS Virus preparations. Viruses were isolated from fecal specimens obtained from patients with infectious hepatitis or were obtained from commercial sources as prototype agents. Viruses were propagated in Blake bottles or stationary tubes of human embryonic lung tissue culture (HEL; E. V. Davis 
RESULTS
Neutralization titers of antisera against adenovirus types 3, 7, and 16 were compared with that of SC8 since protection against SC8 has been reported for these sera. Similarities between adenovirus type 3 and SC8 were clearly indicated by the amounts of neutralizing antibodies measured by tissue culture neutralization tests in antisera absorbed with homologous and heterologous antigens ( Table 1) . Absorption of antisera to adenovirus 3, 7, 16, or SC8 with its homologous antigen caused a complete loss of neutralizing antibody. Similar results were observed in heterologous absorptions only when antisera to adenovirus 3 were absorbed with SC8 antigen or when antisera to SC8 were absorbed with adenovirus 3 antigen. Antisera to adenovirus 16 were partially neutralized by absorption with SC8 antigen, but absorption of these antisera with adenovirus 3 or 7 antigen caused no change. No changes in the neutralization titer of antisera to adenovirus 7 were caused by similar absorption with antigens from adenovirus 3, 16, or SC8.
Antigenic differences between the SC8 virus and the prototype adenovirus 3 were demonstrated in sketches of the immunodiffusion tests ( Fig. IA and B) . Common precipitins were indicated by continuous lines and differences by the number of lines which formed with the homologous and heterologous systems. Precipitin lines between the wells of antisera in Fig. 1A and B were caused by the excess heterologous antigen used in absorbing the sera in the number 2 wells. Differences in precipitin patterns similar to those observed with adenovirus 3 and SC8 were ob- (Fig. 2) . Hemagglutinating activity in the fractionated SC8 preparation was concentrated primarily in fractions obtained prior to those containing the protein. Most of the radioactivity was found in the same fractions; however, considerable quantities of radioactivity persisted in a few fractions after hemagglutinating activity was greatly diminished, and a second minor peak of radioactivity was found in fractions obtained after most of the protein had been eluted (Fig. 2) . On the basis of these observations, consecutive fractions were combined arbitrarily into major fractions A, B, C, and D, so that A contained all of the eluate prior to the appearance of radioactivity, protein, or hemagglutination activity. B contained those portions with the highest hemagglutination titers and easily detectable amounts of radioactivity and protein. C contained the major portion ofthe protein, less radioactivity than B, and a little hemagglutination activity. D contained the remaining radioactivity and protein but no hemagglutination activity.
For purposes of comparison, similar serial chromatographic fractions of the prototype virus and the uninfected tissue culture material were combined quantitatively into major fractions on the basis of eluted volumes. The marked differences observed in radioactive content of comparable serial samples from SC8 and uninfected radioactive tissue culture were also found in the major fractions. Fraction B of SC8 contained about five times as much radioactivity as the control, and fractions C and D each contained two times as much (Fig. 2) .
Hemagglutination studies indicated that the radioactivity was incorporated into the SC8 virus. When African green monkey erythrocytes were Results of neutralization tests with type-specific antisera indicated that the SC8 agent contained an adenovirus type 3, but precipitin patterns formed by immunodiffusion tests provided visual evidence of differences in the antigenic composition of the adenovirus component of SC8 and adenovirus type 3. Four lines were formed in each homologous reaction and two in each heterologous reaction between SC8 and adenovirus type 3 ( Fig. IA and B) . These precipitins probably represented the complement-fixing antigen common to mammalian adenoviruses, the type-specific antigen, and two subgroup antigens. Since precipitins did not form in reactions between SC8 and agent Y antisera or between SC8 antisera and agent X, the precipitins formed in heterologous reaction between SC8 and adenovirus 3 must be associated with antigens from the adenovirus moiety of these agents. After homologous and heterologous absorptions with the respective adenovirus antigens, antisera against SC8 or adenovirus type 3 did not protect tissue culture cells from infection in serum neutralization tests (Table 1 ). These observations suggested that the two precipitins formed by heterologous reactions represented the complement-fixing antigen and the type-specific antigen of adenovirus type 3. Two precipitins were also observed in heterologous reactions between SC8 antiserum and adenovirus types 7 and 16 which were used for comparisons (Fig. 1C) . One of these lines represented the complement-fixing antigen. However, the other, the relationship of which was not understood from these studies, did not represent the respective type-specific antigens, since appreciable changes did not occur in neutralizing capabilities of antisera to adenovirus types 7 and 16 after heterologous absorption with other adenovirus antigens.
Physical differences between SC8 and adenovirus 3 were also suggested by thermal inactivation studies (R. G. Bird et al., in press). The prototype virus was inactivated after heating at 50 C for 15 min, but the SC8 resisted this treatment for 40 min. The differences in thermal lability and in precipitin patterns of SC8 and prototype adenovirus 3 supported the suggestion of Hatch and Siem (8) that the adenovirus moiety of SC8 may be a variant or hybrid strain of adenovirus 3. Other evidence supporting the proposal that SC8 is a variant strain of adenovirus 3 was indicated when adenovirus 3 from different sources was examined by immunodiffusion. Agents studied included other members of the San Carlos group studied by Hatch The amounts of tissue culture infectivity in similar chromatographic fractions indicated additional differences in the antigenic constituents of the SC8 preparation and prototype adenovirus 3.
Comparison of the titers suggested that fraction D of SC8 contained about 103 times the infectivity of fraction D of the prototype preparations. Since the agar columns used for the chromatographic fractionation function as molecular sieves from which larger molecules are eluted first, particles in fraction D must be smaller than particles in fraction B.
The greater infectivity in fraction D of the SC8 preparation seemed to be due to a smaller infective particle not present in the prototype preparation. Visual support for this premise was furnished (R. G. Bird et al., in press) when a particle measuring 40 nm was found in electron micrographs to be associated with an adenovirus type 3 from the San Carlos group. Data obtained from the chromatographic fractionations of the radioactive preparations and from the immunodiffusion studies also supported this suggestion. The CPE produced in tissue culture by agent Y were similar to those observed in the first passage material from chromatographic fractions C and D of SC8. Since typical adenovirus CPE reappeared after a number of subpassages, the original inoculum obviously did contain some adenoviruses, but in insufficient quantity to mask the contaminating smaller agent on the initial passage.
Results of immunodiffusion and chromatographic studies demonstrated that neither agent X, obtained from SC8 material, nor the unidentified agent isolated from blood clots, agent Y, was adenovirus. No precipitin lines common to adenovirus were formed when these antigens were reacted with antisera to the original SC8 or with antisera to other adenoviruses. However, both X and Y formed precipitin lines with antiserum to agent Y. When radioactive preparations of agent Y were separated by chromatography, the distribution of radioactive material in the different fractions was similar to that observed with agent X.
Other investigators studying the adenoviruses (1) have found small agents associated with adenovirus infections in tissue culture and have designated them as adeno-associated viruses (AAV). Present evidence does not relate this small particle to the AAV. In most instances, the AAV were considered to be completely dependent upon the adenovirus and unable to replicate without them. Our studies suggested that agent X, isolated with adenovirus from cases of hepatitis, can multiply without the adenovirus and, in fact, is similar, if not identical, to agent Y, which was isolated without adenoviruses from other cases of hepatitis.
